Literature DB >> 16796589

Estrogen receptor alpha and APOEepsilon4 polymorphisms interact to increase risk for sporadic AD in Italian females.

E Porrello1, M C Monti, E Sinforiani, M Cairati, A Guaita, C Montomoli, S Govoni, M Racchi.   

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease that affects both sexes, with a higher prevalence in women. Declining estrogen levels after menopause may render estrogen target neurons in the brain more susceptible to age or disease-related processes such as AD. To investigate the role of two single nucleotide polymorphisms in the first intron of the ER-alpha gene, denominated PvuII and XbaI, and their interaction with the known AD susceptibility gene APOE, we examined 131 patients with sporadic AD and 109 healthy control subjects. In multinomial logistic regression analysis, a significantly increased risk of sporadic AD because of interaction between the ER-alpha p allele and APOE epsilon4 allele was observed in women, taking subjects who had neither the p allele nor epsilon4 as reference [odds ratio (OR) 7.24; 95% CI, 2.22-23.60]. For women carrying the ER-alpha x allele together with APOE epsilon4, the risk of sporadic AD was similarly elevated (OR 8.33; 95% CI, 1.73-40.06). The data suggest that the p and x alleles of polymorphic ER-alpha gene interact synergistically with the APOE epsilon4 allele to increase the risk of AD in women but not in men in this Italian cohort.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16796589     DOI: 10.1111/j.1468-1331.2006.01333.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  17 in total

1.  Interaction between estrogen receptor-alpha and butyrylcholinesterase genes modulates Alzheimer's disease risk.

Authors:  Onofre Combarros; José Antonio Riancho; Jana Arozamena; Ignacio Mateo; Javier Llorca; Jon Infante; Pascual Sánchez-Juan; María Teresa Zarrabeitia; José Berciano
Journal:  J Neurol       Date:  2007-04-06       Impact factor: 4.849

Review 2.  Transdermal delivery of treatment for Alzheimer's disease: development, clinical performance and future prospects.

Authors:  Agnes L F Chan; Yie W Chien; Shun Jin Lin
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

3.  GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers.

Authors:  R Ramirez-Lorca; M Boada; M E Saez; I Hernandez; A Mauleon; M Rosende-Roca; P Martinez-Lage; M Gutierrez; L M Real; J Lopez-Arrieta; J Gayan; C Antunez; A Gonzalez-Perez; L Tarraga; A Ruiz
Journal:  J Nutr Health Aging       Date:  2009-03       Impact factor: 4.075

4.  Estrogen receptor-alpha variants increase risk of Alzheimer's disease in women with Down syndrome.

Authors:  Nicole Schupf; Joseph H Lee; Michelle Wei; Deborah Pang; Constance Chace; Rong Cheng; Warren B Zigman; Benjamin Tycko; Wayne Silverman
Journal:  Dement Geriatr Cogn Disord       Date:  2008-04-14       Impact factor: 2.959

5.  Estrogen receptor-Beta variants are associated with increased risk of Alzheimer's disease in women with down syndrome.

Authors:  Qi Zhao; Joseph H Lee; Deborah Pang; Alexis Temkin; Naeun Park; Sarah C Janicki; Warren B Zigman; Wayne Silverman; Benjamin Tycko; Nicole Schupf
Journal:  Dement Geriatr Cogn Disord       Date:  2011-12-08       Impact factor: 2.959

Review 6.  Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity.

Authors:  Walter A Rocca; Brandon R Grossardt; Lynne T Shuster
Journal:  Brain Res       Date:  2010-10-18       Impact factor: 3.252

7.  EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP.

Authors:  Jamie Winderbaum Fernandez; Kavon Rezai-Zadeh; Demian Obregon; Jun Tan
Journal:  FEBS Lett       Date:  2010-09-17       Impact factor: 4.124

8.  Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging.

Authors:  Walter A Rocca; Lynne T Shuster; Brandon R Grossardt; Demetrius M Maraganore; Bobbie S Gostout; Yonas E Geda; L Joseph Melton
Journal:  Womens Health (Lond)       Date:  2009-01

9.  Estrogen receptor α variants affect age at onset of Alzheimer's disease in a multiethnic female cohort.

Authors:  S C Janicki; N Park; R Cheng; L N Clark; J H Lee; N Schupf
Journal:  Dement Geriatr Cogn Disord       Date:  2014-04-08       Impact factor: 2.959

10.  Genetic Factors Affecting Late-Onset Alzheimer's Disease Susceptibility.

Authors:  Maryam Rezazadeh; Aziz Khorrami; Tarlan Yeghaneh; Mahnaz Talebi; Seyed Jalal Kiani; Yaser Heshmati; Jalal Gharesouran
Journal:  Neuromolecular Med       Date:  2015-11-09       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.